You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bruton's Tyrosine Kinase

Showing 1 - 25 of 3,916
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
Jan 20, 2023

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tolebrutinib 60mg,

Active, not recruiting
  • Multiple Sclerosis
  • tolebrutinib 60mg
  • tolebrutinib 120mg
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

CNS Lymphoma Trial in Petah Tikva (Imbruvica)

Recruiting
  • Central Nervous System Lymphoma
  • Petah Tikva, Israel
    Hematology Institute
May 9, 2022

Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Leukemia
  • +4 more
  • (no location specified)
Jul 27, 2022

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

Completed
Has Results
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2022

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia
    • London, London, City Of, United Kingdom
    • +9 more
    Jan 13, 2023

    Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2022

    Neuromyelitis Optica Trial in Beijing (zanubrutinib)

    Recruiting
    • Neuromyelitis Optica
    • Beijing, Beijing, China
      XuanWu Hospital
    May 15, 2022

    Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

    Recruiting
    • Immune Thrombocytopenia
    • Bruton Tyrosine Kinase
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Mar 6, 2022

    Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI

    Active, not recruiting
    Has Results
    • Safety and Tolerability
    • +3 more
    • Zoster Vaccine Recombinant, Adjuvanted
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 10, 2022

    REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

    Not yet recruiting
    • CLL, Relapsed
    • +3 more
      • Clermont-Ferrand, France
      • +7 more
      Nov 16, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Not yet recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 10, 2023

      Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • Changchun, China
      • +5 more
      Jan 27, 2023

      Food Allergy, Food Allergy Peanut Trial in Baltimore (Acalabrutinib)

      Recruiting
      • Food Allergy
      • Food Allergy Peanut
      • Baltimore, Maryland
        Johns Hopkins Bayview Medical Center
      Dec 30, 2021

      MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

      Active, not recruiting
      • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
      • +9 more
      • BTK inhibitor PCI-32765
      • +5 more
      • Columbus, Ohio
        Ohio State University Medical Center
      Jun 27, 2022

      MEOI and HRQoL in CLL Patients Treated With BTKis

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Fountain Valley, California
        • +15 more
        Jan 16, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 2, 2022

        Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

        Recruiting
        • Blastoid Variant Mantle Cell Lymphoma
        • +8 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 5, 2022

        Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

        Active, not recruiting
        Has Results
        • Waldenstrom Macroglobulinemia
        • Chiba, Japan
        • +8 more
        Jan 27, 2023

        Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +2 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 4, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 14, 2022